Jessica Kaufman1,2, Kathleen L Bagot1, Jane Tuckerman1,2, Ruby Biezen3, Jane Oliver1,4, Carol Jos1, Darren Suryawijaya Ong1, Jo-Anne Manski-Nankervis3, Holly Seale5, Lena Sanci3, Jane Munro1,6, J Simon Bell7, Julie Leask8, Margie Danchin1,2,6. 1. Murdoch Children's Research Institute, Victoria. 2. Department of Paediatrics, The University of Melbourne, Victoria. 3. Department of General Practice, The University of Melbourne, Victoria. 4. The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Victoria. 5. School of Population Health, University of New South Wales, New South Wales. 6. The Royal Children's Hospital, Victoria. 7. Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Victoria. 8. Susan Wakil School of Nursing and Midwifery, University of Sydney, New South Wales.
Abstract
OBJECTIVE: Tailored communication is necessary to address COVID-19 vaccine hesitancy and increase uptake. We aimed to understand the information needs, perceived benefits and barriers to COVID-19 vaccination of people prioritised, but hesitant to receive the vaccine. METHOD: In this qualitative study in Victoria, Australia (February-May 2021), we purposively sampled hesitant adults who were health or aged/disability care workers (n=20), or adults aged 18-69 with comorbidities or aged ≥70 years ('prioritised adults'; n=19). We thematically analysed interviews inductively, then deductively organised themes within the World Health Organization Behavioural and Social Drivers of vaccination model. Two stakeholder workshops (n=12) explored understanding and preferences for communicating risks and benefits. We subsequently formed communication recommendations. RESULTS: Prioritised adults and health and aged care workers had short- and long-term safety concerns specific to personal circumstances, and felt like "guinea pigs". They saw vaccination as beneficial for individual and community protection and travel. Some health and aged care workers felt insufficiently informed to recommend vaccines, or viewed this as outside their scope of practice. Workshop participants requested interactive materials and transparency from spokespeople about uncertainty. Conclusions and public health implications: Eleven recommendations address communication content, delivery and context to increase uptake and acceptance of COVID-19 vaccines.
OBJECTIVE: Tailored communication is necessary to address COVID-19 vaccine hesitancy and increase uptake. We aimed to understand the information needs, perceived benefits and barriers to COVID-19 vaccination of people prioritised, but hesitant to receive the vaccine. METHOD: In this qualitative study in Victoria, Australia (February-May 2021), we purposively sampled hesitant adults who were health or aged/disability care workers (n=20), or adults aged 18-69 with comorbidities or aged ≥70 years ('prioritised adults'; n=19). We thematically analysed interviews inductively, then deductively organised themes within the World Health Organization Behavioural and Social Drivers of vaccination model. Two stakeholder workshops (n=12) explored understanding and preferences for communicating risks and benefits. We subsequently formed communication recommendations. RESULTS: Prioritised adults and health and aged care workers had short- and long-term safety concerns specific to personal circumstances, and felt like "guinea pigs". They saw vaccination as beneficial for individual and community protection and travel. Some health and aged care workers felt insufficiently informed to recommend vaccines, or viewed this as outside their scope of practice. Workshop participants requested interactive materials and transparency from spokespeople about uncertainty. Conclusions and public health implications: Eleven recommendations address communication content, delivery and context to increase uptake and acceptance of COVID-19 vaccines.
Authors: Penny Lun; Jonathan Gao; Bernard Tang; Chou Chuen Yu; Khalid Abdul Jabbar; James Alvin Low; Pradeep Paul George Journal: PLoS One Date: 2022-10-03 Impact factor: 3.752
Authors: Jessica Kaufman; Kathleen L Bagot; Monsurul Hoq; Julie Leask; Holly Seale; Ruby Biezen; Lena Sanci; Jo-Anne Manski-Nankervis; J Simon Bell; Jane Munro; Carol Jos; Darren Suryawijaya Ong; Jane Oliver; Jane Tuckerman; Margie Danchin Journal: Vaccines (Basel) Date: 2021-12-21